Category: Pfizer BioNTech

Vaccine Antibodies May Start to Fall Six Weeks After Second Shot: UK Study

Antibody levels generated by two doses of the Oxford/AstraZeneca or Pfizer/BioNTech coronavirus vaccine may start to fall six weeks after the second jab, and for some could drop by up to 50 percent in less than three months, research suggests. University College London’s (UCL) Virus Watch study analysed blood from 552 vaccinated people mostly in […]

Vaccine Makers Face Fresh Challenges as COVID Variants Weaken Vaccine Efficacy

Scientists have already started looking for new vaccine candidates for the CCP virus as the mRNA vaccines, such as Pfizer and Moderna, become less effective against increasingly contagious coronavirus mutations, according to new research. The report, published in the U.S.-based New England Journal of Medicine at the beginning of July found that vaccine-induced antibodies were 2.9 […]

BioNTech COVID-19 Vaccine Produces 10 Times More Antibodies Than China’s Sinovac: Study

A new study by researchers in Hong Kong has found that recipients of BioNTech’s Comirnaty COVID-19 vaccine generate 10 times more antibodies than the Chinese CoronaVac vaccine made by Sinovac. The study reported that even after receiving their first BioNTech dose, recipients’ antibody levels were higher than those who had received two doses of Sinovac. The […]

Business Leaders Urge the Government to Set Realistic Vaccine Targets

Australia’s business leaders are pressing the state and federal government to set realistic vaccine targets to reopen Australia after 18 months of pandemic economic pain. This comes after Prime minister Scott Morrison announced the four-step plan at the National Cabinet meeting last Friday, with each phases to be triggered by the achievement of a vaccination […]